MoonLake Immunotherapeutics’ Kristian Reich on how nanobodies will revolutionize immunotherapy скачать в хорошем качестве

MoonLake Immunotherapeutics’ Kristian Reich on how nanobodies will revolutionize immunotherapy

From llamas and camels to humans worldwide. Nanobodies are enjoying success in the clinic and experts are hailing these camelid-derived biologics as one of the next big things in immunotherapy. Kristian Reich is co-founder and CSO of MoonLake Immunotherapeutics. After a long and distinguished career as a clinician and researcher, Kristian helped to launch MoonLake in 2021 and quickly helped move their lead candidate to the clinic. Now, on the verge of Phase III trials, he joins 'Beyond Biotech' to talk nanobodies, innovation, serendipitous science, and the power that comes from never stopping to dream. 01:04               Meet Kristian Reich 05:26               Excited by the science of nanobodies 07:13               MoonLake’s mission 13:12               Milestones at MoonLake 15:24               Introduction to nanobodies 17:55               Serendipitous science 19:46               How nanobodies work 23:18               Global prevalence of immune conditions 24:31               The impact on patients 27:09               Nanobodies in the clinic 31:19               Manufacturing challenges, regulatory challenges 34:04               Working with top pharma 35:55               The future of nanobodies 37:42               The future of MoonLake 39:10               Don’t stop dreaming Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! (https://www.labiotech.eu/advertise/?u...)   Stay updated by subscribing to our newsletter (https://www.labiotech.eu/newsletter/?...)